Common appetite-raising medications include: Corticosteroids (like prednisone) Certain Antidepressants (SSRIs or TCAs) Antipsychotics Some Beta-blockers If you have recently started a new prescription, it could be blunting the appetite-suppression benefits of your GLP-1 treatment
Despite these promising benefits, the FDA's decision to scrutinize BPC-157 is based on several key factors
Effects of once-weekly semaglutide on appetite, energy intake, control of eating, food preference and body weight in subjects with obesity - Diabetes, Obesity & Metabolism Dosing schedule - Ozempic Once-Weekly Semaglutide in Adults with Overweight or Obesity - New England Journal of Medicine Weight Loss Outcomes Associated With Semaglutide Treatment for Patients With Overweight or Obesity - JAMA Semaglutide 24 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, double-blind, double-dummy, placebo-controlled, phase 3 trial - Lancet
Peters S, Mundree SG, Thomson JA, Farrant JM, Keller F